This grant, offered by the National Institute on Drug Abuse, aims to support projects focused on investigating the therapeutic potential of cannabinoids and the endocannabinoid system for the development of mechanism-based pain therapies. Applications are welcome until Sep 07, 2021, 12:00:00 AM EDT.
Opportunity ID: 308885
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-18-917 |
| Funding Opportunity Title: | Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 – Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.213 — Research and Training in Complementary and Integrative Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 10, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 07, 2021 |
| Current Closing Date for Applications: | Sep 07, 2021 |
| Archive Date: | Oct 13, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education Private institutions of higher education Independent school districts For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments State governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to support projects that will elucidate the therapeutic potential of the cannabinoids and endocannabinoid system in the development of mechanism-based therapies for pain. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-18-917.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00244821 | Sep 24, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259275 | Sep 24, 2018 | Sep 07, 2021 | View |
Package 1
Mandatory forms
308885 RR_SF424_2_0-2.0.pdf
308885 PHS398_CoverPageSupplement_4_0-4.0.pdf
308885 RR_OtherProjectInfo_1_4-1.4.pdf
308885 PerformanceSite_2_0-2.0.pdf
308885 RR_KeyPersonExpanded_2_0-2.0.pdf
308885 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
308885 RR_Budget_1_4-1.4.pdf
308885 RR_SubawardBudget30_1_4-1.4.pdf
308885 PHS398_ModularBudget_1_2-1.2.pdf
308885 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
308885 RR_SF424_2_0-2.0.pdf
308885 PHS398_CoverPageSupplement_5_0-5.0.pdf
308885 RR_OtherProjectInfo_1_4-1.4.pdf
308885 PerformanceSite_2_0-2.0.pdf
308885 RR_KeyPersonExpanded_2_0-2.0.pdf
308885 PHS398_ResearchPlan_4_0-4.0.pdf
308885 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
308885 RR_Budget_1_4-1.4.pdf
308885 RR_SubawardBudget30_1_4-1.4.pdf
308885 PHS398_ModularBudget_1_2-1.2.pdf
308885 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
